A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Recruiting · NCT01638676 · Registry updated 2021-10-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 / Phase 2 | 2021-10-29 | NCT01638676 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| James Graham Brown Cancer Center | 6 |
| University of Louisville | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| James Graham Brown Cancer Center-University of Louisville | Louisville | United States | 1 |